Autopsy report · NCT03028909

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

“Study is withdrawn due to company decision.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

MedImmune LLC

Sponsor type

Industry

Conditions

Influenza - Type A Strains

Interventions

Oseltamivir; MEDI8852; Placebo

Participants

0

Trials that died the same way

• A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
  “Study is being withdrawn for business reasons” (89% match in meaning)
• A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
  “Study was withdrawn prior to enrolment due to business decision.” (85% match in meaning)
• A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
  “Study was withdrawn due to scientific and business considerations.” (84% match in meaning)
• A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection
  “Company decision to withdraw before study started” (84% match in meaning)
• Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
  “This study was withdrawn for business reasons.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.